Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00212186 · ClinicalTrials.gov registry record · NA
Selenium Supplementation of Patients With Cirrhosis
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT00212186 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 48 participants.
The verdict
NCT00212186, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether patients with liver disease can improve their nutritional selenium status by taking supplemental selenium.
Interventions
- DRUG Selenium Supplements (essential nutrient)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 1998-10 |
| Est. Completion | 2003-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00212186
The ClinicalTrials.gov registry entry for NCT00212186 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Selenium Supplements (essential nutrient) is the first listed.
NCT00212186 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00212186 about?
NCT00212186 is a clinical study titled "Selenium Supplementation of Patients With Cirrhosis". The purpose of this study is to determine whether patients with liver disease can improve their nutritional selenium status by taking supplemental selenium.
What is the current status of trial NCT00212186?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 1998-10. Estimated completion is 2003-11.
What interventions are being tested in trial NCT00212186?
The interventions under investigation include: Selenium Supplements (essential nutrient) (DRUG).
Who is sponsoring clinical trial NCT00212186?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.